A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2013-09-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose, antitumor activity, safety and
pharmacology of MEDI-575 in combination with carboplatin/paclitaxel in subjects with
previously untreated, advanced non-small cell lung cancer (NSCLC).